Bringing the fundamentals into focus…
Back to Can-Fite BioPharma Ltd.
How Can-Fite BioPharma Ltd. stacks up
CANF · against 1 other Healthcare companies of similar size
Overall
27/ 100
Near the bottom of its peers.
Ranked #2 of 2 · scores higher than 0% of peers
Bars: peers in each 10-point band of the overall score1 peers with an overall score of 20–29, including CANF · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Valuation—Not enough reported data
Growth#2 of 2Score 2 / 100 · beats 0%Profitability#2 of 2Score 1 / 100 · beats 0%Risk#1 of 2Lower relative risk · safety 77 · beats 100%Ranking by overall score
Top 5 and the companies ranked around CANF| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 9M USD | 45 | 8 | 99 | 11 | 1 / 2 | |
| 2 | 5M USD | 27 | 2 | 1 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score